SE7501911L - - Google Patents
Info
- Publication number
- SE7501911L SE7501911L SE7501911A SE7501911A SE7501911L SE 7501911 L SE7501911 L SE 7501911L SE 7501911 A SE7501911 A SE 7501911A SE 7501911 A SE7501911 A SE 7501911A SE 7501911 L SE7501911 L SE 7501911L
- Authority
- SE
- Sweden
- Prior art keywords
- naphth
- yloxy
- hydroxypropyl
- useful
- formula
- Prior art date
Links
- PODKTVHURWLQLF-UHFFFAOYSA-N 1-naphthalen-1-yloxy-3-piperazin-1-ylpropan-2-ol Chemical class C=1C=CC2=CC=CC=C2C=1OCC(O)CN1CCNCC1 PODKTVHURWLQLF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2408804A DE2408804C2 (de) | 1974-02-23 | 1974-02-23 | 1-(2-Methoxyphenyl)-4-[3-(naphth-1-yl-oxy)-2-hydroxy-propyl]-piperazin, dessen Salze, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7501911L true SE7501911L (fr) | 1975-08-25 |
SE405601B SE405601B (sv) | 1978-12-18 |
Family
ID=5908286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7501911A SE405601B (sv) | 1974-02-23 | 1975-02-20 | Forfarande for framstellning av 1-(3-(naft-1-yl-oxi)-2-hydroxipropyl)-piperazinderivat |
Country Status (20)
Country | Link |
---|---|
US (1) | US3997666A (fr) |
JP (1) | JPS6029712B2 (fr) |
AR (1) | AR206339A1 (fr) |
AT (1) | AT340937B (fr) |
BE (1) | BE825755A (fr) |
CA (1) | CA1039282A (fr) |
CH (2) | CH612958A5 (fr) |
DE (1) | DE2408804C2 (fr) |
DK (1) | DK135124C (fr) |
ES (1) | ES434829A1 (fr) |
FI (1) | FI59248C (fr) |
FR (1) | FR2261770B1 (fr) |
GB (1) | GB1445548A (fr) |
IE (1) | IE40678B1 (fr) |
NL (2) | NL175059B (fr) |
PL (1) | PL92131B1 (fr) |
SE (1) | SE405601B (fr) |
SU (2) | SU549085A3 (fr) |
YU (2) | YU37156B (fr) |
ZA (1) | ZA751031B (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2387971A1 (fr) * | 1977-04-19 | 1978-11-17 | Delalande Sa | Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique |
EP0269383A3 (fr) * | 1986-11-21 | 1990-05-02 | A.H. Robins Company, Incorporated | 1-Aryloxy-4-[(4-aryl)-1-pipérazinyl]-2-butanols utiles pour traiter des manifestations allergiques |
US4882330A (en) * | 1986-11-21 | 1989-11-21 | A. H. Robins Company, Incorporated | 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents |
DE3918542A1 (de) * | 1989-06-07 | 1990-12-13 | Boehringer Mannheim Gmbh | Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
DE3918543A1 (de) * | 1989-06-07 | 1990-12-13 | Boehringer Mannheim Gmbh | Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie |
US20020143007A1 (en) * | 1996-02-02 | 2002-10-03 | Garvey David S. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US20050065161A1 (en) * | 1996-02-02 | 2005-03-24 | Nitromed, Inc. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
US6358515B2 (en) | 1997-01-30 | 2002-03-19 | Senju Pharmaceutical Co., Ltd. | Hydroquinone derivatives |
CN1163224C (zh) | 1998-09-30 | 2004-08-25 | 武田药品工业株式会社 | 改善膀胱排泄能力的药物 |
US20020065286A1 (en) * | 2000-08-21 | 2002-05-30 | Davies Michael John | Treatment of wounds |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
US20030229001A1 (en) * | 2002-01-31 | 2003-12-11 | Pfizer Inc. | Treatment of male sexual dysfunction |
OA12905A (en) | 2002-08-19 | 2006-10-13 | Pfizer Prod Inc | Combination therapy for hyperproliferative diseases. |
GB0219961D0 (en) | 2002-08-28 | 2002-10-02 | Pfizer Ltd | Oxytocin inhibitors |
US7323462B2 (en) * | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
CA2451267A1 (fr) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Utilisations pharmaceutiques de ligands alpha2delta |
KR20070091049A (ko) | 2002-12-13 | 2007-09-06 | 워너-램버트 캄파니 엘엘씨 | 하부요로증상을 치료하기 위한 알파-2-델타 리간드 |
PA8597401A1 (es) * | 2003-03-14 | 2005-05-24 | Pfizer | Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
KR20060021870A (ko) | 2003-05-30 | 2006-03-08 | 랜박시 래보러터리스 리미티드 | 치환된 피롤 유도체와 hmg―co 억제제로서의 이의용도 |
US20050065158A1 (en) * | 2003-07-16 | 2005-03-24 | Pfizer Inc. | Treatment of sexual dysfunction |
US7291640B2 (en) * | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
DE602006003416D1 (de) | 2005-03-21 | 2008-12-11 | Pfizer Ltd | Substituierte triazolderivate als oxytocinantagonisten |
EP1917257A1 (fr) * | 2005-08-10 | 2008-05-07 | Pfizer Limited | Derives de triazole substitues en tant qu'antagonistes d'oxytocine |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
WO2007054896A1 (fr) | 2005-11-08 | 2007-05-18 | Ranbaxy Laboratories Limited | Procede de preparation de sel hemicalcique d’acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
JP5483880B2 (ja) | 2006-10-23 | 2014-05-07 | 武田薬品工業株式会社 | イミノピリジン誘導体およびその用途 |
US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
US8481569B2 (en) * | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
US20110039892A1 (en) * | 2008-04-23 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
CN101671317B (zh) * | 2009-10-09 | 2011-04-27 | 蚌埠丰原涂山制药有限公司 | 一种萘哌地尔的制备方法 |
CN101747293B (zh) * | 2009-12-29 | 2011-12-07 | 蚌埠丰原涂山制药有限公司 | 萘哌地尔的制备方法 |
JP5807423B2 (ja) * | 2011-07-21 | 2015-11-10 | 大日本印刷株式会社 | ナフトピジルの製造方法 |
CN102816136A (zh) * | 2012-09-18 | 2012-12-12 | 通化吉通药业有限公司 | 萘哌地尔制备方法 |
JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体 |
US9272980B2 (en) | 2014-06-06 | 2016-03-01 | Ktn Biotec, Inc. | Anticancer agent |
WO2016055901A1 (fr) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Composés d'amide substitué |
JOP20210193A1 (ar) | 2019-01-18 | 2023-01-30 | Astrazeneca Ab | مثبطات pcsk9 وطرق استخدامها |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA967965A (en) * | 1968-12-24 | 1975-05-20 | Hoffmann-La Roche Limited | Aromatic ethers and process for the manufacture thereof |
GB1317479A (en) * | 1970-11-10 | 1973-05-16 | Pfizer Ltd | 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives |
DE2235597A1 (de) * | 1972-07-20 | 1974-01-31 | Boehringer Mannheim Gmbh | 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung |
-
0
- NL NLAANVRAGE7501877,A patent/NL175059C/xx active
-
1974
- 1974-02-23 DE DE2408804A patent/DE2408804C2/de not_active Expired
-
1975
- 1975-01-01 AR AR257639A patent/AR206339A1/es active
- 1975-01-28 US US05/544,719 patent/US3997666A/en not_active Expired - Lifetime
- 1975-02-12 CA CA219,883A patent/CA1039282A/fr not_active Expired
- 1975-02-17 GB GB656975A patent/GB1445548A/en not_active Expired
- 1975-02-18 ES ES434829A patent/ES434829A1/es not_active Expired
- 1975-02-18 YU YU0382/75A patent/YU37156B/xx unknown
- 1975-02-18 DK DK58175A patent/DK135124C/da not_active IP Right Cessation
- 1975-02-18 FI FI750449A patent/FI59248C/fi not_active IP Right Cessation
- 1975-02-18 NL NLAANVRAGE7501877,A patent/NL175059B/xx not_active IP Right Cessation
- 1975-02-19 ZA ZA00751031A patent/ZA751031B/xx unknown
- 1975-02-20 SE SE7501911A patent/SE405601B/xx not_active IP Right Cessation
- 1975-02-20 BE BE153540A patent/BE825755A/fr not_active IP Right Cessation
- 1975-02-20 JP JP50021386A patent/JPS6029712B2/ja not_active Expired
- 1975-02-21 AT AT132375A patent/AT340937B/de not_active IP Right Cessation
- 1975-02-21 IE IE359/75A patent/IE40678B1/xx unknown
- 1975-02-21 CH CH1023478A patent/CH612958A5/xx not_active IP Right Cessation
- 1975-02-21 FR FR7505511A patent/FR2261770B1/fr not_active Expired
- 1975-02-21 CH CH218575A patent/CH609342A5/xx not_active IP Right Cessation
- 1975-02-21 SU SU2112509A patent/SU549085A3/ru active
- 1975-02-21 PL PL1975178230A patent/PL92131B1/pl unknown
-
1976
- 1976-01-07 SU SU2308659A patent/SU561514A3/ru active
-
1981
- 1981-04-21 YU YU1044/81A patent/YU37157B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7501911L (fr) | ||
SE7406513L (sv) | Gastrinsyrasekretionsmedel. | |
AU529426B2 (en) | 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity | |
FR2275210B1 (fr) | ||
ES430709A1 (es) | Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol. | |
ES8102561A1 (es) | Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles | |
ES419814A1 (es) | Un procedimiento de preparacion de un nuevo derivado amini-co del 1,4-benzodioxano. | |
ES415000A1 (es) | Procedimiento para la preparacion de difenil-alea-noilami- nopiridinas. | |
ES416495A1 (es) | Un procedimiento para la preparacion de nuevos derivados deacido quinaldico. | |
ES504206A0 (es) | Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5 | |
BG42677A3 (en) | Method for preparing of 6- alpha- methylcorticoides | |
GB1539473A (en) | N-aryl-n-(1-l-4-piperidinyl)-arylacetamides | |
ES438044A1 (es) | Procedimiento para preparar 2-amino-1, 3-tiazinas. | |
ES432027A1 (es) | Un procedimiento para la preparacion de anilinobenzotiazo- les. | |
ES431432A1 (es) | Procedimiento para preparar derivados de acido indanacetico. | |
ES414955A1 (es) | Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles. | |
ZA874470B (en) | New tetrahydrobenzothiazoles,and the preparation and use thereof | |
ES434828A1 (es) | Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxil)-propil)-piperizina. | |
ES437197A1 (es) | Procedimiento para preparar 5-feniltetrazoles sustituidos. | |
ES451296A1 (es) | Un procedimiento para la preparacion de derivados de esoin- dol. | |
SE7708452L (sv) | Komposition innehallande en antrakinonforening | |
ES455832A1 (es) | Procedimientos para la preparacion de derivados de la pipe- ridina. | |
SE7506729L (sv) | Forfarande for framstellning av nya substituerade 1-(2',4',6'-trihydrofenyl)-propandion-(1,2)-foreningar | |
ES433081A1 (es) | Un procedimiento de preparacion de un compuesto espiro. | |
ES398080A1 (es) | Procedimiento para la preparacion de derivados de 1-vinil- carbonil-piperazina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7501911-7 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7501911-7 Format of ref document f/p: F |